Design Therapeutics, Inc.(DSGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DSGN Design Therapeutics, Inc.

交易中 07-18 10:13:33 EDT

4.42

-0.04

-0.90%

最高4.42	最低4.32	成交量6,861
今开4.42	昨收4.46	日振幅2.24%
总市值2.50亿	流通市值1.07亿	总股本5,650万
成交额3.00万	换手率0.03%	流通股本2,430万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"DSGN","market":"US","secType":"STK","nameCN":"Design Therapeutics, Inc.","latestPrice":4.42,"timestamp":1721311998770,"preClose":4.46,"halted":0,"volume":6861,"delay":0,"floatShares":24295488,"shares":56495039,"eps":-1.045309,"marketStatus":"交易中","marketStatusCode":2,"change":-0.04,"latestTime":"07-18 10:13:33 EDT","open":4.42,"high":4.42,"low":4.32,"amount":30024.326046,"amplitude":0.022422,"askPrice":4.44,"askSize":202,"bidPrice":4.38,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-1.045309,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721332800000},"adr":0,"listingDate":1616731200000,"adjPreClose":4.46,"preHourTrading":{"tag":"盘前","latestPrice":4.4,"preClose":4.46,"latestTime":"09:27 EDT","volume":162,"amount":677.4993900000001,"timestamp":1721309271100},"postHourTrading":{"tag":"盘后","latestPrice":4.46,"preClose":4.46,"latestTime":"16:03 EDT","volume":7203,"amount":32125.38,"timestamp":1721246593597},"volumeRatio":0.35148,"impliedVol":0.7545,"impliedVolPercentile":0.0714},"requestUrl":"/m/hq/s/DSGN","defaultTab":"news","newsList":[{"id":"2451915231","title":"Design Therapeutics, Inc.盘中异动 股价大涨5.02%报4.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451915231","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451915231?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:28","pubTimestamp":1721140128,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日22时28分，Design Therapeutics, Inc.股票出现波动，股价急速拉升5.02%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162228489681d367&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162228489681d367&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","DSGN","BK4505","BK4139","LENZ"],"gpt_icon":0},{"id":"2450539873","title":"Design Therapeutics, Inc.盘中异动 早盘快速上涨5.66%报4.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450539873","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450539873?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:00","pubTimestamp":1720792809,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时00分，Design Therapeutics, Inc.股票出现波动，股价快速上涨5.66%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712220009af921dfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712220009af921dfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4505","DSGN","LENZ","BK4139"],"gpt_icon":0},{"id":"2450637753","title":"Design Therapeutics, Inc.盘中异动 股价大涨5.25%报3.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450637753","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450637753?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:00","pubTimestamp":1720706409,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时00分，Design Therapeutics, Inc.股票出现波动，股价快速上涨5.25%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220009941f6480&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220009941f6480&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","DSGN","BK4505","BK4139","LENZ"],"gpt_icon":0},{"id":"2443059934","title":"Design Therapeutics, Inc.盘中异动 急速下跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443059934","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443059934?lang=zh_cn&edition=full","pubTime":"2024-06-13 03:25","pubTimestamp":1718220328,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日03时25分，Design Therapeutics, Inc.股票出现异动，股价急速跳水5.46%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613032529aef49dc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613032529aef49dc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","DSGN","BK4505","BK4139","LENZ"],"gpt_icon":0},{"id":"2441094146","title":"Design Therapeutics, Inc.盘中异动 股价大跌5.62%报3.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441094146","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441094146?lang=zh_cn&edition=full","pubTime":"2024-06-08 02:11","pubTimestamp":1717783911,"startTime":"0","endTime":"0","summary":"北京时间2024年06月08日02时11分，Design Therapeutics, Inc.股票出现异动，股价急速跳水5.62%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608021151af8cae53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608021151af8cae53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","DSGN","LENZ","BK4139","BK4505"],"gpt_icon":0},{"id":"2439505301","title":"Design Therapeutics, Inc.盘中异动 急速下挫5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439505301","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439505301?lang=zh_cn&edition=full","pubTime":"2024-05-30 01:25","pubTimestamp":1717003530,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日01时25分，Design Therapeutics, Inc.股票出现异动，股价急速跳水5.46%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.85%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530012530af8af202&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530012530af8af202&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DSGN","BK4539","LENZ","BK4505"],"gpt_icon":0},{"id":"2437303021","title":"Design Therapeutics, Inc.盘中异动 股价大涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437303021","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437303021?lang=zh_cn&edition=full","pubTime":"2024-05-24 21:37","pubTimestamp":1716557872,"startTime":"0","endTime":"0","summary":"北京时间2024年05月24日21时37分，Design Therapeutics, Inc.股票出现波动，股价大幅拉升5.58%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524213752aef19540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524213752aef19540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","DSGN","BK4505"],"gpt_icon":0},{"id":"2433722854","title":"Design Therapeutics, Inc.盘中异动 早盘股价大涨5.09%报4.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433722854","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433722854?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:51","pubTimestamp":1715176298,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时51分，Design Therapeutics, Inc.股票出现波动，股价急速上涨5.09%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。消息层面，截至21时51分，Design Therapeutics, Inc.股票正面舆情新闻比例50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508215138861ebc8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508215138861ebc8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","LENZ","BK4505","DSGN"],"gpt_icon":0},{"id":"2433200822","title":"Design Therapeutics, Inc.盘中异动 股价大涨7.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433200822","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433200822?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:32","pubTimestamp":1715088769,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时32分，Design Therapeutics, Inc.股票出现异动，股价快速上涨7.67%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。消息层面，截至21时32分，Design Therapeutics, Inc.股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721324987dc9e4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721324987dc9e4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","DSGN","LENZ","BK4139","BK4505"],"gpt_icon":0},{"id":"2433724078","title":"美国研究综述-ServiceNow、Ulta Beauty、Vertex Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2433724078","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433724078?lang=zh_cn&edition=full","pubTime":"2024-05-07 16:20","pubTimestamp":1715070052,"startTime":"0","endTime":"0","summary":"    路透5月7日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 ServiceNow、Ulta Beauty 和 Vertex Pharmaceuticals。要闻  * 艾睿电子  ：雷蒙德-詹姆斯将目标价从130美元上调至135美元 * Cardinal Health Inc   ：杰富瑞将目标价从110美元下调至105美元 * ServiceNow Inc   ：贝雅将目标价从870美元上调至885美元 * Ulta Beauty Inc   ：奥本海默将目标价从500美元下调至475美元 * Vertex Pharmaceuticals Inc   ：Piper Sandler将目标价从450美元上调至456美元 以下是路透周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX","FRPT","VERX","LMND","KRC","LU1064131342.USD","ACT","CTO","LU0889566641.SGD","HIMS","BCRX","PACS","BK4567","NOW","BV","BK4550","COTY","DSGN","HWM","ACHC","LINC","LITE","GLYC","ENTA","CIVI","VRTX","EVER","CTRA","CAH","FIS","APA","BK4117","AIG","GOOD","ARW","IR","BECN","MCHP","LYRA","ACA","BOWL","GOSS","PLTR","ATI","BK4204","BK4097","IART","PNW","MTZ"],"gpt_icon":0},{"id":"2432622975","title":"Design Therapeutics Inc   预计每股亏损26美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432622975","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432622975?lang=zh_cn&edition=full","pubTime":"2024-05-03 19:55","pubTimestamp":1714737309,"startTime":"0","endTime":"0","summary":"   * Design Therapeutics Inc    预计在5月7日公布截至2024年3月31日的业绩时，季度收入将没有变化(预计)    *    * LSEG 的分析师平均预计 Design Therapeutics Inc 每股亏损 26 美分。* 华尔街对 Design Therapeutics Inc 的 12 个月目标价中位数为 4.00 美元，高于其上次收盘价 3.65 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSGN","LENZ"],"gpt_icon":0},{"id":"2432858459","title":"Design Therapeutics, Inc.盘中异动 大幅下跌5.11%报3.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432858459","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432858459?lang=zh_cn&edition=full","pubTime":"2024-05-01 03:58","pubTimestamp":1714507108,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日03时58分，Design Therapeutics, Inc.股票出现波动，股价快速跳水5.11%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050103582887e85232&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050103582887e85232&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","DSGN","BK4505"],"gpt_icon":0},{"id":"2426694462","title":"Design Therapeutics, Inc.盘中异动 早盘股价大跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426694462","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426694462?lang=zh_cn&edition=full","pubTime":"2024-04-11 22:21","pubTimestamp":1712845287,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日22时21分，Design Therapeutics, Inc.股票出现波动，股价急速下跌5.53%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.07%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc 是一家从事 GeneTACTM 分子研发的临床阶段生物制药公司，GeneTACTM 分子是一类新型的小分子基因靶向嵌合治疗候选药物，旨在通过解决由遗传核苷酸重复扩增突变引起的疾病的潜在原因来改善疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411222127861e4ff8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411222127861e4ff8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","DSGN","BK4505","BK4139","LENZ"],"gpt_icon":0},{"id":"2424043113","title":"Design Therapeutics, Inc.盘中异动 早盘股价大跌5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424043113","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424043113?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:31","pubTimestamp":1712064669,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时31分，Design Therapeutics, Inc.股票出现异动，股价急速跳水5.69%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.14%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc 是一家从事 GeneTACTM 分子研发的临床阶段生物制药公司，GeneTACTM 分子是一类新型的小分子基因靶向嵌合治疗候选药物，旨在通过解决由遗传核苷酸重复扩增突变引起的疾病的潜在原因来改善疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040221310987e7d9dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040221310987e7d9dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","DSGN","BK4139","LENZ","BK4505"],"gpt_icon":0},{"id":"2422613965","title":"Design Therapeutics, Inc.盘中异动 股价大涨5.35%报3.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422613965","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422613965?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:30","pubTimestamp":1711459840,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时30分，Design Therapeutics, Inc.股票出现异动，股价急速拉升5.35%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc 是一家从事 GeneTACTM 分子研发的临床阶段生物制药公司，GeneTACTM 分子是一类新型的小分子基因靶向嵌合治疗候选药物，旨在通过解决由遗传核苷酸重复扩增突变引起的疾病的潜在原因来改善疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262130417a4f340a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262130417a4f340a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DSGN","LENZ","BK4505","BK4539"],"gpt_icon":0},{"id":"2420242697","title":"Design Therapeutics, Inc.2023财年实现净利润-66.86百万美元，同比减少5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420242697","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420242697?lang=zh_cn&edition=full","pubTime":"2024-03-20 23:16","pubTimestamp":1710947779,"startTime":"0","endTime":"0","summary":"12月31日，Design Therapeutics, Inc.公布财报，公告显示公司2023财年净利润为-66.86百万美元，同比减少5.61%；其中营业收入为0.00美元，每股基本收益为-1.19美元。从资产负债表来看，Design Therapeutics, Inc.总负债11.96百万美元，其中短期债务716000.00美元，资产负债比为0.25，流动比率为0.30。机构评级：截至2023年12月31日，当前有3家机构对Design Therapeutics, Inc.目标价做出预测，其中目标均价为4.67美元，其中最低目标价为4.00美元，最高目标价为6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320231629879dab42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320231629879dab42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSGN"],"gpt_icon":0},{"id":"2419713812","title":"Design Therapeutics Inc   预计每股亏损31美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2419713812","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419713812?lang=zh_cn&edition=full","pubTime":"2024-03-16 04:56","pubTimestamp":1710536168,"startTime":"0","endTime":"0","summary":"   * Design Therapeutics Inc    将于3月19日公布截至2023年12月31日的财报，预计该公司的季度收入将保持不变。*    * LSEG分析师对Design Therapeutics Inc的平均预期是每股亏损31美分。* 华尔街对 Design Therapeutics Inc 的 12 个月目标价中位数为 4.50 美元，高于其最新收盘价 2.48 美元。3月15日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSGN"],"gpt_icon":0},{"id":"2419986410","title":"Design Therapeutics, Inc.盘中异动 早盘急速跳水5.04%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419986410","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419986410?lang=zh_cn&edition=full","pubTime":"2024-03-14 23:01","pubTimestamp":1710428486,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日23时01分，Design Therapeutics, Inc.股票出现异动，股价急速跳水5.04%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc 是一家从事 GeneTACTM 分子研发的临床阶段生物制药公司，GeneTACTM 分子是一类新型的小分子基因靶向嵌合治疗候选药物，旨在通过解决由遗传核苷酸重复扩增突变引起的疾病的潜在原因来改善疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314230126861de45a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314230126861de45a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4505","BK4139","DSGN"],"gpt_icon":0},{"id":"2417039017","title":"Design Therapeutics Inc   预计每股亏损31美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2417039017","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417039017?lang=zh_cn&edition=full","pubTime":"2024-03-08 19:06","pubTimestamp":1709896000,"startTime":"0","endTime":"0","summary":"   * Design Therapeutics Inc    预计在公布截至2023年12月31日的财报时，季度收入将保持不变。*    * LSEG 的分析师平均预计 Design Therapeutics Inc 每股亏损 31 美分。* 华尔街对 Design Therapeutics Inc 的 12 个月目标价中位数为 4.50 美元，高于其最新收盘价 2.85 美元。3月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSGN"],"gpt_icon":0},{"id":"2411354407","title":"Design Therapeutics Inc盘中异动 快速上涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411354407","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411354407?lang=zh_cn&edition=full","pubTime":"2024-02-15 23:21","pubTimestamp":1708010496,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日23时21分，Design Therapeutics Inc股票出现异动，股价大幅上涨5.60%。Design Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.57%。Design Therapeutics Inc公司简介：Design Therapeutics Inc 是一家从事 GeneTACTM 分子研发的临床阶段生物制药公司，GeneTACTM 分子是一类新型的小分子基因靶向嵌合治疗候选药物，旨在通过解决由遗传核苷酸重复扩增突变引起的疾病的潜在原因来改善疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021523213787e7038b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021523213787e7038b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSGN","BK4539","BK4505","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.designtx.com","stockEarnings":[{"period":"1week","weight":0.232},{"period":"1month","weight":0.1675},{"period":"3month","weight":0.1925},{"period":"6month","weight":0.906},{"period":"1year","weight":-0.3656},{"period":"ytd","weight":0.683}],"compareEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":0.018},{"period":"3month","weight":0.115},{"period":"6month","weight":0.1544},{"period":"1year","weight":0.2262},{"period":"ytd","weight":0.1717}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Design Therapeutics, Inc.于2017年12月18日根据特拉华州法律成立。他们是一家临床阶段的生物制药公司，开创了新的小分子治疗候选物，称为GeneTACs，旨在用于疾病治疗。某些核苷酸重复扩增疾病，如FA，可导致特异性mRNAs表达降低；在其他疾病，如强直性肌营养不良1型(DM1)、FECD和Huntington病，核苷酸重复扩增可导致毒性基因产物的产生，通常与病理性核病灶有关。他们的基因被设计成选择性地与基因重复序列结合，通过恢复或阻断mRNA转录来调节基因表达，并恢复细胞健康。作为一个平台，他们相信GeneTACs在单基因核苷酸重复序列扩增疾病中具有广泛的潜在适用性。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.250058},{"month":2,"riseRate":0.666667,"avgChangeRate":0.04907},{"month":3,"riseRate":0.666667,"avgChangeRate":0.151963},{"month":4,"riseRate":0.25,"avgChangeRate":-0.098031},{"month":5,"riseRate":0.5,"avgChangeRate":0.01688},{"month":6,"riseRate":0.5,"avgChangeRate":-0.04322},{"month":7,"riseRate":0.75,"avgChangeRate":0.200779},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.215736},{"month":9,"riseRate":0,"avgChangeRate":-0.096213},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.044663},{"month":11,"riseRate":0.666667,"avgChangeRate":0.046787},{"month":12,"riseRate":0.666667,"avgChangeRate":0.038666}],"exchange":"NASDAQ","name":"Design Therapeutics, Inc.","nameEN":"Design Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Design Therapeutics, Inc.(DSGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Design Therapeutics, Inc.(DSGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Design Therapeutics, Inc.,DSGN,Design Therapeutics, Inc.股票,Design Therapeutics, Inc.股票老虎,Design Therapeutics, Inc.股票老虎国际,Design Therapeutics, Inc.行情,Design Therapeutics, Inc.股票行情,Design Therapeutics, Inc.股价,Design Therapeutics, Inc.股市,Design Therapeutics, Inc.股票价格,Design Therapeutics, Inc.股票交易,Design Therapeutics, Inc.股票购买,Design Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Design Therapeutics, Inc.(DSGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Design Therapeutics, Inc.(DSGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}